CCX872-B

· Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCX872-B, covering 2025-02-27 to 2025-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma [Phase 1]